We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Highlights: Phase I trial agreement with leading clinical research organization Human safety and tolerability study to assess infusion of RECCE® 327 in 40 healthy subjects as a single ascending...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.02 | 4.30107526882 | 0.465 | 0.495 | 0.455 | 160056 | 0.46545101 | DE |
4 | -0.07 | -12.6126126126 | 0.555 | 0.57 | 0.38 | 229797 | 0.47892091 | DE |
12 | 0.01 | 2.10526315789 | 0.475 | 0.57 | 0.38 | 156826 | 0.49797645 | DE |
26 | -0.16 | -24.8062015504 | 0.645 | 0.655 | 0.38 | 173102 | 0.49692234 | DE |
52 | 0.035 | 7.77777777778 | 0.45 | 0.695 | 0.38 | 155038 | 0.49149256 | DE |
156 | -0.415 | -46.1111111111 | 0.9 | 1.38 | 0.38 | 145641 | 0.64146121 | DE |
260 | 0.23 | 90.1960784314 | 0.255 | 1.875 | 0.21 | 246412 | 0.78520192 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions